Grace Capital’s Gilead Sciences GILD Stock Holding History

Grace Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$661K	Hold	9,100	–	–	0.39%	76
2021 Q3	$616K	Sell	9,100 -2,200	-19%	-$155K	0.38%	82
2021 Q2	$778K	Hold	11,300	–	–	0.52%	57
2021 Q1	$730K	Hold	11,300	–	–	0.46%	60
2020 Q4	$658K	Sell	11,300 -1,600	-12%	-$96.5K	0.42%	67
2020 Q3	$815K	Sell	12,900 -2,800	-18%	-$194K	0.63%	39
2020 Q2	$1.21M	Sell	15,700 -2,000	-11%	-$153K	1.04%	24
2020 Q1	$1.32M	Sell	17,700 -2,000	-10%	-$138K	1.3%	19
2019 Q4	$1.28M	Sell	19,700 -1,300	-6%	-$84.7K	1.04%	19
2019 Q3	$1.33M	Sell	21,000 -2,165	-9%	-$142K	1.34%	15
2019 Q2	$1.56M	Sell	23,165 -52	-0.2%	-$3.42K	0.75%	42
2019 Q1	$1.51M	Sell	23,217 -15,897	-41%	-$1.06M	0.59%	58
2018 Q4	$2.45M	Buy	39,114 +6,493	+20%	+$454K	1.14%	23
2018 Q3	$2.52M	Sell	32,621 -8,864	-21%	-$669K	0.98%	32
2018 Q2	$2.94M	Buy	41,485 +7,315	+21%	+$517K	1.12%	24
2018 Q1	$2.52M	Sell	34,170 -18,993	-36%	-$1.51M	1.34%	29
2017 Q4	$3.81M	Buy	+53,163	New	+$4.04M	1.34%	33

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grace Capital's GILD Position: Q4 2021 in Review

Grace Capital held its Gilead Sciences (GILD) position steady in Q4 2021 at 9,100 shares worth $661K. The position accounts for 0.39% of the portfolio, ranked #76.

Grace Capital first reported a position in GILD in Q4 2017 and has held it in 17 quarters since. The position peaked at $3.81M in Q4 2017. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Grace Capital held 9,100 shares of Gilead Sciences worth $661K as of Q4 2021.
Grace Capital left its Gilead Sciences share count unchanged in Q4 2021.
Gilead Sciences made up 0.39% of Grace Capital's portfolio in Q4 2021, its #76 holding.
Grace Capital first reported a position in Gilead Sciences in Q4 2017 and has held it in 17 quarters since.
Grace Capital's Gilead Sciences position peaked at $3.81M in Q4 2017.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.